Cargando…

Recent advances and optimal management of human epidermal growth factor receptor-2-positive early-stage breast cancer

With the introduction of anthracycline-based regimens, 5-year survival rates have significantly improved in patients with early-stage breast cancer. With the addition of trastuzumab, a monoclonal antibody targeting the human epidermal growth factor receptor-2 (HER2), improvements in overall survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batoo, Sameer, Bayraktar, Soley, Al-Hattab, Eyad, Basu, Sandeep, Okuno, Scott, Glück, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961084/ https://www.ncbi.nlm.nih.gov/pubmed/31949426 http://dx.doi.org/10.4103/jcar.JCar_14_19

Ejemplares similares

Immunotherapy in breast cancer
por: Bayraktar, Soley, et al.
Publicado: (2019)

Patient Understanding of Chemotherapy and Goals of Care as Provided by Different Care Team Members
por: Suhail, Shanzay, et al.
Publicado: (2023)

Detection of BCR-ABL Positive Cells in an Asymptomatic Patient: A Case Report and Literature Review
por: Bayraktar, Soley, et al.
Publicado: (2010)

Recent Advances in Flexible Sensors and Their Applications
por: Zazoum, Bouchaib, et al.
Publicado: (2022)

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer
por: Lv, Huimin, et al.
Publicado: (2021)

Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Sotelo, Miguel J, et al.
Publicado: (2021)

Recent advances in optimization
por: Seeger, Alberto
Publicado: (2006)

Recent Positive Selection in Genes of the Mammalian Epidermal Differentiation Complex Locus
por: Goodwin, Zane A., et al.
Publicado: (2017)

Recent advances in computational optimization
por: Fidanova, Stefka
Publicado: (2013)

Recent Advances in Combinatorial Optimization
por: Xu, Dehua, et al.
Publicado: (2015)

Esophageal cancer presenting with atrial fibrillation: A case report
por: Bayraktar, Ulas Darda, et al.
Publicado: (2008)

Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis
por: Hasegawa, Akito, et al.
Publicado: (2020)

Recent advances in Japanese encephalitis
por: Basu, Anirban, et al.
Publicado: (2017)

Symposium on Recent Advances in Optimization Techniques
por: Lavi, Abrahim, et al.
Publicado: (1966)

Recent advances in early stage lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Recent Advances in Cardiac Surgery. A Review
por: Basu, A. K.
Publicado: (1952)

Recent advances in evolutionary multi-objective optimization
por: Bechikh, Slim, et al.
Publicado: (2017)

Recent advances in the management of carcinoma of the rectum
por: Basu, Somprakas, et al.
Publicado: (2009)

Current therapy and recent advances in the management of retinoblastoma
por: Meel, Rachna, et al.
Publicado: (2012)

Recent advances in non-intubated robotic-assisted thoracic surgery (NiRATS) for tracheal/airway resection and reconstruction
por: Kösek, Volkan, et al.
Publicado: (2021)

Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report
por: Sakaguchi, Masazumi, et al.
Publicado: (2019)

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
por: Shay, Rebecca C., et al.
Publicado: (2020)

Recent Advances in Kidney Bioengineering
por: Cintron Pregosin, Nina, et al.
Publicado: (2021)

Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
por: Shen, Le-Sang, et al.
Publicado: (2020)

Optimal allocation of leaf epidermal area for gas exchange
por: de Boer, Hugo J., et al.
Publicado: (2016)

Point-of-Care Diagnostics: Recent Advances and Trends
por: Vashist, Sandeep Kumar
Publicado: (2017)

Assessment of the association of the MOGAT1 and MOGAT3 gene with growth traits in different growth stages in Holstein calves
por: Gökçe, Gökhan, et al.
Publicado: (2022)

Recent advances in computational optimization: results of the workshop on computational optimization WCO 2017
por: Fidanova, Stefka
Publicado: (2018)

Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases
por: Gebbia, Vittorio
Publicado: (2022)

Recent advances in cancer outcomes in HIV-positive smokers
por: Ranjit, Sabina, et al.
Publicado: (2018)

Recent advances in computational optimization: results of the workshop on computational optimization and numerical search and optimization 2018
por: Fidanova, Stefka
Publicado: (2019)

Advanced hormone receptor-positive/human epidermal growth factor receptor 2-positive invasive ductal carcinoma with cecal metastasis: A case report
por: Yang, Si-Yuan, et al.
Publicado: (2023)

Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer
por: Hu, Na, et al.
Publicado: (2022)

Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy
por: Amanda, Gina, et al.
Publicado: (2017)

Recent Advances in Butterfly Optimization Algorithm, Its Versions and Applications
por: Makhadmeh, Sharif Naser, et al.
Publicado: (2022)

Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer
por: Kahraman, Seda, et al.
Publicado: (2021)

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer
por: McIntyre, Kristi, et al.
Publicado: (2014)

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
por: Brufsky, Adam M.
Publicado: (2015)

Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
por: Boér, Katalin
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r558bb8vgdt8t3m28c19bpj53a